Standard BioTools Inc.LABNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR-3.0%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-3.0%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 48.17% |
| 2024 | -231.40% |
| 2023 | 51.56% |
| 2022 | -102.83% |
| 2021 | -185.79% |
| 2020 | 56.21% |
| 2019 | -39.72% |
| 2018 | -4.58% |
| 2017 | 38.37% |
| 2016 | -12.69% |